Patent Assignment
Reel/Frame 022868/0365
Merger
Recorded: 2009-06-24
Received: 2009-06-24
Pages: 113
Assignor
BAYER HEALTHCARE AG
Executed: 2008-12-30
Assignee
BAYER SCHERING PHARMA AKTIENGESELLSCHAFT
MULLERSTRASSE 178, BERLIN, DEX, 13353, GERMANY
Covered Properties
(5)
2-Phenyl Substituted Imidazotriazinones as Phosphodiesterase Inhibitors
Application:
12/004,933 →
2-Phenyl Substituted Imidazotriazinones as Phosphodiesterase Inhibitors, for Treatment of Hypertension
Application:
11/409,417 →
2-Phenyl Substituted Imidazotriazinones as Phosphodiesterase Inhibitors
Application:
10/923,544 →
2-Phenyl Substituted Imidazotriazinones as Phosphodiesterase Inhibitors
Application:
10/365,740 →
2-Phenyl Substituted Imidatriazinones as Phosphodiesterase Inhibitors
Application:
09/943,530 →